Abstract
Oxidative stress (OS) and cardiovascular (CV) reactivity are related to CV morbidity and mortality. However, little is known about the relationships between these CV risk factors and their confounders. We hypothesize that higher OS is linked to higher blood pressure (BP) reactivity to acute laboratory stressors and in the natural setting. We studied 137 subjects with a family history of hypertension and early myocardial infarction. There were 63 European Americans (EAs) (38 males) and 74 African Americans (AAs) (35 males), aged 19–36 (27.6±3.1). The protocol included a competitive video game, cold stressor and ambulatory BP recording. Blood samples were drawn six times for OS markers (8-hydroxydeoxyguanosine (8-OHdG) and 8-Isoprostane) assay. Repeated measures analyses of covariance were used to test for mean differences and Pearson correlations were used to test OS and BP associations. There were no significant race/ethnicity differences in BP reactivity to either stressor (both P’s>0.48). 8-OHdG levels were significantly lower across all time points for AAs than for EAs (P<0.05), while levels of 8-isoprostane did not differ significantly (P>0.10). Averaged 8-OHdG levels significantly correlated with systolic blood pressure (SBP) reactivity (r=0.45, <0.01) and 24-h, daytime and nighttime SBP (r range=0.37–0.42, all P’s<0.02) for EAs but not for AAs, whereas 8-isoprostane levels were significantly correlated with reactive SBP and nighttime diastolic blood pressure (DBP) (both r’s=0.38, P<0.01) for AAs but not for EAs. These findings suggest a link between OS and BP changes in subjects at high risk for CV disease (CVD). Further, race/ethnicity determines which OS marker will impact BP variation implying race/ethnicity differences in OS-related mechanisms of CVD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jones DW, Hall JE . Racial and ethnic differences in blood pressure: biology and sociology. Circulation 2006; 114: 2757–2759.
Wrobel MJ, Figge JJ, Izzo JL Jr . Hypertension in diverse populations: a New York State Medicaid clinical guidance document. J Am Soc Hypertens 2011; 5: 208–229.
Kershaw KN, Diez Roux AV, Burgard SA, Lisabeth LD, Mujahid MS, Schulz AJ . Metropolitan-level racial residential segregation and black-white disparities in hypertension. Am J Epidemiol 2011; 174: 537–545.
Mills PJ, Dimsdale JE, Ziegler MG, Nelesen RA . Racial differences in epinephrine and beta 2-adrenergic receptors. Hypertension 1995; 25: 88–91.
Treiber F, Del Rosario J, Davis H, Gutin B, Strong WB . Cardiovascular stress responses predict cardiovascular functioning: a four-year follow-up. Longitudinal cardiovascular stress responses. In:. Children and Exercise XIX: Promoting Health and Well-being. Proceedings of the Xixth International Symposium of the European Group of Pediatric Work, Moretonhampstead, Exeter, UK; 2013, pp 366-372.
Treiber F, Harshfield G, Davis H, Kapuku G, Moore D . Stress responsivity and body fatness: links between socioeconomic status and cardiovascular risk factors in youth. Ann NY Acad Sci 1999; 896: 435–438.
Treiber FA, Jackson RW, Davis H, Pollock JS, Kapuku G, Mensah GA et al. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension 2000; 35: 722–725.
Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, Taylor T . Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med 2003; 65: 46–62.
Harshfield GA, Alpert BS, Pulliam DA, Willey ES, Somes GW, Stapelton FB . Sodium excretion and racial differences in ambulatory blood pressure patterns. Hypertension 1991; 18: 813–818.
Mata-Greenwood E, Chen DB . Racial differences in nitric oxide-dependent vasorelaxation. Reprod Sci 2008; 15: 9–25.
Falkner B . The role of cardiovascular reactivity as a mediator of hypertension in African Americans. Semin Nephrol 1996; 16: 117–125.
Hertz RP, Unger AN, Cornell JA, Saunders E . Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165: 2098–2104.
Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke 2006; 37: 1171–1178.
Wong MD, Shapiro MF, Boscardin WJ, Ettner SL . Contribution of major diseases to disparities in mortality. N Engl J Med 2002; 347: 1585–1592.
Ong KL, Cheung BM, Man YB, Lau CP, Lam KS . Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49: 69–75.
Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006; 119: 70.e9–15.
Vaziri ND, Rodriguez-Iturbe B . Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006; 2: 582–593.
Morrow JD . Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005; 25: 279–286.
Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K et al. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365–374.
Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417: 150–152.
Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA . Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 2001; 18: 109–115.
Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR and Multi-Ethnic Study of Atherosclerosis. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007; 194: 245–252.
Lopes HF, Morrow JD, Stojiljkovic MP, Goodfriend TL, Egan BM . Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens 2003; 16: 331–336.
Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ . Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000; 36: 878–884.
Ceriello A . Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008; 31 ((Suppl 2)): S181–S184.
Treiber F, Musante L, GKapuku, Davis C, Litaker M, Davis H . Cardiovascular (CV) responsivity and recovery to acute stress and future CV functioning in youth with family histories of CV disease: a 4-year longitudinal study. Int J Psychophysiol 2001; 41: 65–74.
Kapuku GK, Treiber FA, Davis HC, Harshfield GA, Cook BB, Mensah GA . Hemodynamic function at rest, during acute stress, and in the field: predictors of cardiac structure and function 2 years later in youth. Hypertension 1999; 34: 1026–1031.
Treiber FA, Musante L, Kapuku G, Davis C, Litaker M, Davis H . Cardiovascular (CV) responsivity and recovery to acute stress and future CV functioning in youth with family histories of CV disease: a 4-year longitudinal study. Int J Psychophysiol 2001; 41: 65–74.
Treiber FA, Raunikar RA, Davis H, Fernandez T, Levy M, Strong WB . One year stability and prediction of cardiovascular functioning at rest and during laboratory stressors in youth with family histories of hypertension. Int J Behav Med 1994; 1: 335–353.
Musante L, Turner JR, Treiber FA, Davis H, Strong WB . Moderators of ethnic differences in vasoconstrictive reactivity in youth. Ethn Dis 1996; 6: 224–234.
Treiber FA, Davis H, Thompson WO, Raunikar A, Strong WB, Levy M . Anthropometric, demographic and psychosocial moderators of children's vascular reactivity. Psychosom Med 1994; 56: 170.
Banerjee M, Kang KH, Morrow JD, Roberts LJ, Newman JH . Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol 1992; 263: H660–H663.
Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC . Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 1999; 34: 983–986.
Weinberger MH . Racial differences in renal sodium excretion: relationship to hypertension. Am J Kidney Dis 1993; 21: 41–45.
Schmidlin O, Forman A, Tanaka M, Sebastian A, Morris RC Jr . NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonate. Hypertension 1999; 33: 633–639.
Fredrickson M . Racial differences in reactivity to behavioral challenge in essential hypertension. J Hypertens 1986; 4: 325–331.
Subash P, Premagurumurthy K, Sarasabharathi A, Cherian KM . Total antioxidant status and oxidative DNA damage in a South Indian population of essential hypertensives. J Hum Hypertens 2010; 24: 475–482.
Irie M, Asami S, Nagata S, Ikeda M, Miyata M, Kasai H . Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res 2001; 92: 367–376.
Irie M, Asami S, Nagata S, Miyata M, Kasai H . Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health 2001; 74: 153–157.
Huang CJ, Webb HE, Evans RK, McCleod KA, Tangsilsat SE, Kamimori GH et al. Psychological stress during exercise: immunoendocrine and oxidative responses. Exp Biol Med (Maywood) 2010; 235: 1498–1504.
Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M et al. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 2002; 22: 438–442.
Demirbag R, Yilmaz R, Erel O . The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005; 39: 172–176.
Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MHC . In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405–411.
Olusi SO . Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159–1164.
Keaney JF Jr., Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434–439.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752–1761.
Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, Ducimetiere P et al. High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 1998; 27: 808–813.
Wang H, Li H, Hou Z, Pan L, Shen X, Li G . Role of oxidative stress in elevated blood pressure induced by high free fatty acids. Hypertens Res 2009; 32: 152–158.
Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001; 50: 159–165.
Beaubien ER, Card CM, Card SE, Biem HJ, Wilson TW . Accuracy of the Dinamap 1846 XT automated blood pressure monitor. J Hum Hypertens 2002; 16: 647–652.
Acknowledgements
This study was supported by NIH (Gregory Harshfield): P01HL069999-07; NIH (Gaston Kapuku): 5R01 HL076696-04.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kapuku, G., Treiber, F., Raouane, F. et al. Race/ethnicity determines the relationships between oxidative stress markers and blood pressure in individuals with high cardiovascular disease risk. J Hum Hypertens 31, 70–75 (2017). https://doi.org/10.1038/jhh.2016.39
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2016.39
This article is cited by
-
Serum Malondialdehyde Levels in Hypertensive Patients: A Non-invasive Marker of Oxidative Stress. A Systematic Review and Meta-analysis
High Blood Pressure & Cardiovascular Prevention (2022)